Key points are not available for this paper at this time.
Background: The extent of breast ptosis and deformityafter massive weight loss is severe and the treatment of thisproblem is challenging. Recently, there has been a great deal ofinterest and several studies on augmentation mastopexy in thisunique patient population due to the large number of patientswho present after bariatric surgery.Objective: This study aims to describe a useful guide for asingle-stage augmentation mastopexy that combines the benefitsof the submuscular plane with a superior dermoglandularflap for massive weight loss patients (MWLP) with grade 3breast ptosis.Methods: A retrospective cohort included 54 MWLP withgrade 3 breast ptosis (nipple below the inframammary fold andlowest part of the breast) who underwent single-stage augmentationmastopexy between January 2016 and December 2020.Results: The mean age of the patients was 32.4 years(range: 20 to 50 years), the mean current BMI was 26.6kg/m2,and the mean follow-up time was 22 months (range: 13 to 56months).The patients reported outcome of the BREAST -Q scaleswere as follows: Physical well-being (89.3), sexual well-being(88.6), and psychosocial well-being (89.3).The overall incidence of complications was of 18.52%.Mild wound healing problems in 6 patients. Reoperation in 4cases (7.4%) due to implant malposition within 6 months postoperatively.Conclusion: The study results showed that single stageaugmentation mastopexy should be limited to patients withgood breast symmetry and patients who desire rational volumeaugmentation.
Saad Mohamed Saad Ibrahiem (Mon,) studied this question.